Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: William Burns, Christoph Franz, Steven Averbuch, Michael Kolodziek

Premium

Roche said this week that William Burns will not stand for re-election to the board of directors. The company also said that it has proposed that Christoph Franz be elected as chairman of the board, and the remaining members of the board should be re-elected.

The remaining board members include Andre Hoffman; Andreas Oeri; Pius Baschera; John Irving Bell; Paul Bulcke; DeAnne Julius; Severin Schwan; Peter Voser; Arthur Levinson; and Beatrice Weder di Mauro.


The Personalized Medicine Coalition has appointed Steven Averbuch and Michael Kolodziek to seats on its board of directors.

Averbuch is VP of translational clinical diagnostic development and pharmacodiagnostics at Bristol-Myers Squibb and Kolodziek is national medical director of Oncology Solutions.

The two new members will join the board as the terms of Joanne Armstrong and Nancy Simonian expire at the end of 2013.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.